Onco-primary Care Networking to Support TEAM-based Care (ONE TEAM)
Blood Pressure, Hypertension, Cancer
About this trial
This is an interventional prevention trial for Blood Pressure
Eligibility Criteria
Inclusion Criteria:
A total of 800 individuals who fall under the following criteria will be enrolled:
Diagnosed with any of the following selected solid tumors -
- Stage I-III breast [female], colorectal, endometrial, head/neck [H/N], and prostate cancer
- Stage I-II non-small cell lung cancer [NSCLC]
- Treated with curative intent
- 18-79 years old
- Has at least one of three CVD comorbidities (hypertension, diabetes, or hypercholesterolemia) - based upon whether the patient is currently on a medication for the comorbidity at time of recruitment
- Had a visit with their PCP in the previous 12 months
Supplement:
A sample size of 2800-3000 patients will be pulled from the Duke Cancer Registry. The retrospective cohort will consist of older adults ≥65 years who have ≥1 CVD comorbidity (hypertension, type 2 diabetes, dyslipidemia) and underwent cancer surgery for solid tumors (breast, prostate, colorectal, endometrial, gastric, esophageal, liver, pancreatic, renal cell, bladder, ovarian, head/neck, and non-small cell lung cancer) at DUHS from January 1st, 2017 to December 31st 2019.
The qualitative component of the supplement will involve 12-20 PCPs who are participating in the ONE TEAM Study. Eligible PCP participants will be English-speaking providers who have provided care to ≥1 older adult patient who has undergone cancer surgery within a 12-month period at DUHS.
Exclusion Criteria:
Individuals with a history of the following conditions will be ineligible:
- Myocardial infarction in the previous 24 months
- Stage III-IV heart failure (EF <30%)
- Stage IV-V chronic kidney disease (eGFR <30)
Participants who progress to metastatic disease during the course of the 18-month study period will be allowed to continue to participate unless they voluntarily withdraw from the study.
Sites / Locations
- Duke University Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Control
iGuide Intervention
40 PCP clinics; 400 patients
40 PCP clinics; 400 patients